386 related articles for article (PubMed ID: 31142340)
1. FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancer.
Piasecka D; Braun M; Kitowska K; Mieczkowski K; Kordek R; Sadej R; Romanska H
J Exp Clin Cancer Res; 2019 May; 38(1):230. PubMed ID: 31142340
[TBL] [Abstract][Full Text] [Related]
2. FGFR signalling in women's cancers.
Fearon AE; Gould CR; Grose RP
Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer.
Francavilla C; O'Brien CS
Open Biol; 2022 Feb; 12(2):210373. PubMed ID: 35193394
[TBL] [Abstract][Full Text] [Related]
4. FGFR-targeted therapeutics for the treatment of breast cancer.
De Luca A; Frezzetti D; Gallo M; Normanno N
Expert Opin Investig Drugs; 2017 Mar; 26(3):303-311. PubMed ID: 28121208
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
[TBL] [Abstract][Full Text] [Related]
6. Advances and challenges in targeting FGFR signalling in cancer.
Babina IS; Turner NC
Nat Rev Cancer; 2017 May; 17(5):318-332. PubMed ID: 28303906
[TBL] [Abstract][Full Text] [Related]
7. Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?
Bedussi F; Bottini A; Memo M; Fox SB; Sigala S; Generali D
Expert Opin Ther Targets; 2014 Jun; 18(6):665-78. PubMed ID: 24833241
[TBL] [Abstract][Full Text] [Related]
8. Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer.
Shee K; Yang W; Hinds JW; Hampsch RA; Varn FS; Traphagen NA; Patel K; Cheng C; Jenkins NP; Kettenbach AN; Demidenko E; Owens P; Faber AC; Golub TR; Straussman R; Miller TW
J Exp Med; 2018 Mar; 215(3):895-910. PubMed ID: 29436393
[TBL] [Abstract][Full Text] [Related]
9. Recent developments and advances of FGFR as a potential target in cancer.
Xue WJ; Li MT; Chen L; Sun LP; Li YY
Future Med Chem; 2018 Sep; 10(17):2109-2126. PubMed ID: 30066580
[TBL] [Abstract][Full Text] [Related]
10. New Insights in the Interaction of FGF/FGFR and Steroid Receptor Signaling in Breast Cancer.
Pérez Piñero C; Giulianelli S; Lamb CA; Lanari C
Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34977930
[TBL] [Abstract][Full Text] [Related]
11. Rationale for targeting fibroblast growth factor receptor signaling in breast cancer.
André F; Cortés J
Breast Cancer Res Treat; 2015 Feb; 150(1):1-8. PubMed ID: 25677745
[TBL] [Abstract][Full Text] [Related]
12. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
Dianat-Moghadam H; Teimoori-Toolabi L
Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
[TBL] [Abstract][Full Text] [Related]
13. Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.
Cerliani JP; Guillardoy T; Giulianelli S; Vaque JP; Gutkind JS; Vanzulli SI; Martins R; Zeitlin E; Lamb CA; Lanari C
Cancer Res; 2011 May; 71(10):3720-31. PubMed ID: 21464042
[TBL] [Abstract][Full Text] [Related]
14. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention.
Mahapatra S; Jonniya NA; Koirala S; Ursal KD; Kar P
J Biomol Struct Dyn; 2023; 41(22):13509-13533. PubMed ID: 36995019
[TBL] [Abstract][Full Text] [Related]
15. Targeting the fibroblast growth factor receptor family in cancer.
Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
[TBL] [Abstract][Full Text] [Related]
16. De-regulated FGF receptors as therapeutic targets in cancer.
Knights V; Cook SJ
Pharmacol Ther; 2010 Jan; 125(1):105-17. PubMed ID: 19874848
[TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibition of fibroblast growth factor receptors in cancer.
Liang G; Chen G; Wei X; Zhao Y; Li X
Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
[TBL] [Abstract][Full Text] [Related]
18. Targeting FGFR with BGJ398 in Breast Cancer: Effect on Tumor Growth and Metastasis.
Sahores A; May M; Sequeira GR; Fuentes C; Jacobsen B; Lanari C; Lamb CA
Curr Cancer Drug Targets; 2018; 18(10):979-987. PubMed ID: 29237381
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors.
Hierro C; Rodon J; Tabernero J
Semin Oncol; 2015 Dec; 42(6):801-19. PubMed ID: 26615127
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast.
Villanueva H; Grimm S; Dhamne S; Rajapakshe K; Visbal A; Davis CM; Ehli EA; Hartig SM; Coarfa C; Edwards DP
J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):237-248. PubMed ID: 30338425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
